Taiwan News12m
SpringWorks Therapeutics Announces FDA Approval of GOMEKLIâ„¢ (mirdametinib) for the Treatment of Adult and Pediatric Patients with NF1-PN
GOMEKLIâ„¢ is an oral, small molecule MEK inhibitor approved in the United States for the treatment of adult and pediatric patients 2 years of age and older with neurofibromatosis type 1 (NF1) who have ...
EUR/USD Forecast Today 11/02: Trade Spat Fears (Chart)
The euro has gapped lower to kick off the trading week, as we continue to see a lot of volatility in this pair. <li /> As it is likely t ...
ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages GSK plc Investors to Secure Counsel Before Important Deadline in Securities Class Action - GSK
To join the GSK class action, go to https://rosenlegal.com/submit-form/?case_id=34609 or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] for information on the class ...
CoinJournal2h
iDEGEN’s value skyrockets with its listing in the horizon
The cryptocurrency market has continued to show resilience in the wake of trade tensions. Most majors have recorded some ...
JD Supra4h
Regulatory and Commercial Updates on Bio-Thera’s BAT2506 (golimumab)
Bio-Thera had entered into an exclusive licensing agreement with STADA Arzneimittel AG to commercialize BAT2506 in the European Union (UK), the United Kingdom (UK), Switzerland, and selected other ...
Le Lézard4h
OCT Holdings Announces Rebrand to Octavian Therapeutics, Appointment of New Chair and Fundraising Launch
Octavian Therapeutics ("Octavian" or "the Company"), a leading clinical-stage innovator in neuropathic pain treatment, today announces a transformative rebrand, the appointment of a new Non-Executive ...
Biogen stock hits 52-week low at $139.7 amid challenges
Biogen Inc. (NASDAQ:BIIB) shares tumbled to a 52-week low of $139.7, reflecting a stark downturn in the biotechnology firm's market performance. With a market capitalization of $20.38 billion and a ...
EuropaWire5h
Patients as Partners® Europe Launches the 9th Annual Event with 2025 Keynotes, Featured Speakers and Topics
The Conference Forum has announced the 9th annual Patients as Partners® Europe event, scheduled for May 20-21, 2025, at the Royal National Hotel ...
EMA establish advisory portal for high-risk medical devices
The EMA anticipates that the ability to access scientific advice will foster innovation among medical device manufacturers.
Moleculin Announces First European Approval for Phase 3 AML Trial
HOUSTON - Moleculin Biotech, Inc. (NASDAQ:MBRX), a late-stage pharmaceutical company currently trading near its 52-week low of $0.66, announced it has received the first European regulatory approval ...
EUR/USD gains as US Dollar drops ahead of Fed Powell’s testimony
EUR/USD rises to near 1.0330 in Tuesday’s North American session as the US Dollar (USD) drops ahead of the Federal Reserve (Fed) Chair Jerome Powell’s testimony before Congress at 15:00 GMT. The US ...
The Manila Times8h
BEYONTTRA™ (acoramidis), the First Near Complete TTR Stabilizer (≥90%), Approved by the European Commission to Treat ATTR-CM
1 Christoffersen M et al. Transthyretin Tetramer Destabilization and Increased Mortality in the General Population. JAMA ...